Antifungal Strategy in Patients with Invasive Fungal Disease Associated with Hematological Malignancies Based on Risk Stratification

Table 8

Overall effectiveness difference between the 3 groups (7 days after stopping treatment).

Groups	Effective	Ineffective/death	value
Group-1 (n = 183)	156 (85.2%)	27 (14.%)	0.049
Group-2 (n = 62)	47 (75.8%)	15 (24.2%)
Group-3 (n = 33）	23 (69.7%)	10 (0.3%)

Group-1: patients with one risk factor; group-2: patients with two risk factors; group-3: patients with more than three risk factors.